Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium p-aminosalicylate vs streptomycin for first retreatment pulmonary tuberculosis
ChiCTR2000036179Phase 4Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aminosalicylate sodium in pulmonary tuberculosis (TB) (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoints: Liver function test and Sputum culture conversion. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
aminosalicylate sodium
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2000036179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036179.